Last updated on August 2016

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter study of the Analgesic Efficacy and Safety Of A Dose Titration Regimen For The Subcutaneous Administration Of Tanezumab In Subjects with Osteoarthritis Of The Hip Or Knee


Brief description of study

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter study of the Analgesic Efficacy and Safety Of A Dose Titration Regimen For The Subcutaneous Administration Of Tanezumab In Subjects with Osteoarthritis Of The Hip Or Knee

Detailed Study Description

This is A randomized, double-blind, placebo-controlled, multicenter, parallel-group, study of the efficacy and safety of Tanezumab when administered by SC injection for 16 weeks compared to placebo in subjects osteoarthritis of the Knee or hip. Subjects will receive a total of two injections, separated by 8 weeks.

Clinical Study Identifier: TX145055

Contact Investigators or Research Sites near you

Start Over

Christina Stahl

Quality Medical Research
Nashville, TN USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.